Leukapheresis Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921996|
|出版日期||內容資訊||英文 113 Pages
|白血球分離療法市場:成長，趨勢，及預測 Leukapheresis Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 113 Pages||
The Leukapheresis Market is expected to grow with a CAGR of 7.5%, during the forecast period. Leukapheresis is a laboratory procedure in which white blood cells including leukemia cells are separated from a sample of blood. Leukemia is a different type of cancer from most of the other cancers that start in the bone marrow where new blood cells are made. Leukemia starts in early forms of blood cells, usually white blood cells or leucocytes, which helps to fight against infections caused by foreign particles. People with leukemia, produce too many blood cells, and they aren't normal they travel in the blood and go all over the body and cause problems depending upon the organs involved. The incidence of leukemia is highest among whites and lowest among Chinese, Japanese, and Koreans in both men and women and the highest among men than women. Some of the signs and symptoms of leukemia are fatigue and weakness, bleeding from gums, trauma, bruising, fever, weight loss, etc. According to International Agency for Research on Cancer (IARC), in the year 2018 number of leukemia cases for both sexes were estimated as 437,033 cases of leukemia (2.6%), in men 249,454 cases of leukemia (2.8%), in women 187,579 cases of leukemia (2.3%) globally. Rising incidence and prevalence of leukemia and growing demand for leukapheresis procedures are the key driving factors in the leukapheresis market.
Leukapheresis is a laboratory procedure in which white blood cells including leukemia cells are separated from the blood. Leukapheresis is segmented by Type (Leukapheresis Devices (Apheresis Devices, Leukapheresis Columns, and Cell Separators, Leukoreduction Filters), Leukapheresis Disposables), Application and Geography.
Leukapheresis Disposables Segment is Expected to Hold a Major Market Share in the Leukapheresis
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold the largest market share in the global leukapheresis market due to a rise in the geriatric population, increasing prevalence and incidence of leukemia in this region. According to the Leukemia and Lymphoma Society (LLS), in the year 2019, approximately 61,780 people were expected to be diagnosed with leukemia. According to the Leukemia and Lymphoma Society and American Cancer Society, from 2011-2015, in the United States leukemia was the sixth most common cause of cancer deaths in both men and women. Moreover, increasing clinical research activities and a larger presence of biotech and pharma companies is fueling the growth of the overall regional market to a large extent.
The Leukapheresis Market is consolidated competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Macopharma, Fresenius SE & Co. KGaA, HemaCare, Key Biologics LLC, AllCells, StemExpress.